Robotic Surgery Systems

THINK Surgical, Inc. is an orthopedic surgical robotics innovator headquartered in Fremont, CA. The company develops miniature, wireless robotic systems designed to assist surgeons in performing total knee replacement (TKR) procedures. THINK Surgical's core mission centers on implant choice and democratization of robotic technology—differentiating itself by enabling surgeons to select from multiple implant manufacturers rather than locking them into a single proprietary ecosystem. The company's primary product portfolio includes the TMINI® Miniature Robotic System, a compact, wireless robotic platform for knee replacement surgery. Supporting this is TPLAN®, a proprietary software platform that generates individualized 3D surgical plans from patient CT scans, and the Implant Data Hub (ID-HUB), a proprietary database of partner implants that provides surgeons access to multiple implant choices compatible with the TMINI system. THINK Surgical has announced successful clinical cases using TMINI with partner implant systems, including Stryker's Triathlon® Knee System and b-ONE Ortho Corporation's MOBIO® Total Knee System, validating the multi-implant compatibility approach. The company positions itself at the intersection of orthopedic surgery and robotic-assisted surgery, serving hospital systems and surgeons seeking to maintain implant selection flexibility while leveraging robotic precision and planning capabilities. As of the latest updates (2025–2026), THINK Surgical is actively commercializing the TMINI system and expanding clinical adoption.

Intuitive Surgical, Inc. is a global leader in robotic-assisted surgical systems and digital health solutions. The company manufactures the da Vinci family of robotic surgery platforms, which enable minimally invasive surgical procedures across multiple specialties including general surgery, urology, gynecology, cardiothoracic, and orthopedics. Core product lines include the da Vinci 5 (advanced integrated robotic platform with surgeon console and patient cart), the da Vinci SP (single-port robotic system for new surgical approaches), and the Ion robotic bronchoscopy system for lung cancer diagnosis and biopsy. Intuitive also manufactures da Vinci instruments and accessories designed for precision and ergonomic control. Beyond hardware, the company provides digital solutions including My Intuitive (data analytics and insights platform for surgical teams) and SimNow (surgeon training and simulation software). The company operates a global infrastructure with expanded direct operations in Europe and provides 24/7 service and support. Intuitive's systems are used in hospitals worldwide for minimally invasive surgery, and the company has established itself as the market leader in robotic-assisted surgical technology since its founding in 1995. The platform emphasizes surgeon autonomy, precision, and patient outcomes through advanced visualization and control systems.

Stryker Corporation is a global medical technology company headquartered in Portage, Michigan, serving hospitals, surgical centers, and healthcare providers worldwide. The company manufactures and distributes a comprehensive portfolio of medical devices, surgical equipment, implants, and visualization systems across multiple specialties including orthopedics, neurosurgery, spine, trauma, cardiovascular, endoscopy, acute care, and emergency medicine. Key product categories include joint replacement implants (hips, knees) with Mako Robotic-Arm Assisted Technology, neurosurgical and spine instruments with 3D-printed technologies, minimally invasive surgical systems (laparoscopy, arthroscopy, endoscopy), emergency care equipment, communications systems for patient environments, interventional spine products (vertebroplasty, radiofrequency ablation), craniomaxillofacial solutions, sports medicine implants, and neurovascular stroke care devices. Stryker operates manufacturing facilities in multiple countries including Canada, China, and the US. The company maintains a strong commitment to sustainability through device reprocessing and remanufacturing services for single-use medical devices. With regional headquarters and distribution centers across the Americas, Europe, Asia-Pacific, and Middle East & Africa, Stryker provides integrated sales, service, and technical support. The company is regulated by the FDA and maintains global certifications for medical device manufacturing and quality management systems.

EPTAM Precision Solutions is a high-precision contract manufacturer specializing in close-tolerance machined and injection-molded components for mission-critical medical, aerospace & defense, and semiconductor applications. Founded in 1981 and headquartered in Northfield, New Hampshire, EPTAM serves the medical device industry with expertise in producing components for orthopedic implants, interventional cardiology devices, minimally invasive surgical instruments, and surgical robotics platforms. The company offers comprehensive capabilities including precision plastic injection molding, liquid silicone rubber (LSR) molding, metals machining, micro-machining, laser cutting and welding, and additive manufacturing. EPTAM provides integrated design-for-manufacturing (DFM) consultation, tooling development, production scaling, and quality assurance aligned with medical device regulatory standards. The company operates dedicated rapid prototyping facilities (READI) for fast-turn development and maintains approximately 152–500 employees. EPTAM partners with leading OEMs in biotech diagnostics, biopharma manufacturing, medical robotics, and implant sectors to accelerate time-to-market and ensure consistent product quality.

Medtronic is a global healthcare technology leader serving 79+ million patients across diagnostic imaging, surgical and operating room equipment, intensive care, specialty medical, and homecare sectors. The company manufactures and distributes a comprehensive portfolio spanning cardiac rhythm and diagnostics systems, pacemakers, implantable cardioverter-defibrillators, deep brain stimulation devices, robotic surgery platforms, ventilators, anesthesia machines, infusion pumps, continuous glucose monitoring systems, insulin pumps, endoscopic and surgical navigation systems, and wound closure products. Recent FDA clearances include the Stealth AXiS surgical system for spine surgery and pulsed field ablation (PFA) technologies for atrial fibrillation treatment. Medtronic serves hospitals, surgical centers, critical care units, interventional labs, and home care settings through product lines in cardiac, vascular, neuromodulation, minimally invasive surgery, respiratory, and diabetes management. The company conducts 170+ active clinical trials, invests $2.7B annually in R&D, and holds FDA 510(k) clearances, CE marks, and ISO 13485 certification. Manufacturing and distribution capabilities span North America, Europe, and international markets with customer support available 24/7.

Moon Surgical is a French-American medical device company headquartered in San Carlos, California, specializing in AI-powered robotic assistance for minimally invasive surgery. The company develops the Maestro™ platform, a digital surgical assistant robot designed to enhance surgeon autonomy and efficiency during laparoscopic and soft tissue procedures. The platform features dual robotic arms for instrument manipulation and incorporates ScoPilot™, an FDA-cleared AI-enhanced intraoperative guidance tool powered by NVIDIA Holoscan. Maestro is compatible with multiple surgical specialties including abdominal, thoracic, urology, and gynecology procedures. The system has received FDA 510(k) clearance and CE marking, with commercial deployments at leading U.S. and European surgical centers including Lee Health and Surgeon's Point Surgery Center. Moon Surgical focuses on improving patient safety, streamlining operating room workflows, and making advanced robotic-assisted surgery accessible to a broad range of surgical teams while maintaining surgeon control and decision-making authority.

Akesis, Inc. is a medical device manufacturer specializing in advanced radiation therapy systems for oncology and neurosurgery applications. Founded in 2017 and based in Concord, California, the company develops stereotactic radiosurgery (SRS) and linear accelerator platforms featuring patented continuous 360° rotational technology with real-time imaging capabilities. The Akesis Galaxy Platform combines gamma-beam therapy with rotational delivery to optimize treatment planning and dose distribution, while the Akesis Gemini360RT is a modularized linear accelerator platform with multiple imaging options. Both systems support fractionated and single-fraction treatments with high conformality and real-time guidance. Akesis serves healthcare providers ranging from small rural centers to large academic health systems and has received FDA 510(k) clearance for its platforms.

ProNova Solutions is a US-based medical device manufacturer and subsidiary of Provision Healthcare, LLC, specializing in advanced proton therapy beam delivery systems for cancer treatment. The company was founded by leaders who revolutionized cancer diagnostics through CT-PET integration and now applies that expertise to proton therapy innovation. ProNova's flagship product is the SC360 Proton Therapy System, the world's first and only 360° superconducting compact proton therapy system. This advanced system features a patented compact gantry design that creates a larger rectangular treatment room footprint while maintaining low energy consumption and construction costs. The SC360 supports sophisticated treatment modalities including SBRT (Stereotactic Body Radiation Therapy), with future capabilities for Arc and FLASH radiation therapy. Beyond clinical applications, ProNova operates a dedicated Radiation-Effects Program providing a specialized proton beam testing facility for semiconductor manufacturers, space industry, and aviation applications to assess mission-critical component reliability. The company is led by President and CEO Dr. Moataz Karmalawy and maintains a world-class technical operations team committed to advancing cancer treatment accessibility and improving clinical workflows through precision engineering and patient-centered innovation.

Quantum Surgical is a French medical robotics and AI company founded in 2017, specializing in robotic-assisted interventional oncology. Headquartered in Montpellier with a Miami office, the company develops and markets the Epione® robotic platform—a CE-marked and FDA 510(k)-cleared system designed for percutaneous tumor ablation in abdominal, chest, and musculoskeletal lesions. Epione integrates planning, navigation, targeting, and ablation confirmation into a single workflow, enabling minimally invasive treatment of early-stage and challenging tumors that are difficult to reach or surgically inaccessible. The platform has treated over 1,500 patients at 20+ cancer centers in Europe and North America. The Epione system standardizes access to ablation therapy, reducing procedural complexity while improving patient safety, reducing recovery time, and enabling outpatient procedures. Quantum Surgical also acquired NeuWave Medical, expanding its portfolio in thermal ablation technologies. With 130+ employees and recognition including the 2022 Prix Galien USA award, the company continues expanding market approvals and clinical installations.

Point Robotics MedTech Inc. is a leading developer of surgical navigation systems and robotic-assisted surgery platforms designed to advance minimally invasive orthopedic and neurological procedures. The company specializes in assistive surgical robotics with integrated navigation technologies that enhance surgical precision, safety, and reliability in the operating room. Point Robotics' flagship offering, the Kinguide Agile Robotic Arm Surgical Stereotactic System (Taiwan TFDA-approved), combines real-time trajectory guidance, optical tracking, and broad 3D imaging compatibility to reduce surgical variability and improve patient outcomes. The company emphasizes clinically proven minimally invasive solutions for spinal surgery and related orthopedic applications, with commitment to innovation in robotic-assisted surgical technologies that deliver measurable clinical benefits to physicians and healthcare institutions.

ZAP Surgical Systems is a medical technology company specializing in advanced surgical robotics for cranial stereotactic radiosurgery (SRS). Founded in 2014 by Dr. John R. Adler, inventor of the CyberKnife system, ZAP develops the ZAP-X Gyroscopic Radiosurgery platform—a self-shielded, vault-free radiosurgery system using linear accelerator technology for precise, non-invasive treatment of brain tumors and lesions. The ZAP-X platform eliminates the need for expensive radiation bunkers, uses no radioactive cobalt sources, and features real-time dosimetry validation with dual independent gantry design to protect neurocognitive function. The company also offers the ZAP-Axon Radiosurgery Planning System (FDA and EU cleared). With global installations in leading medical institutions, ZAP expands access to high-quality, cost-effective cranial SRS in diverse clinical settings—from suburban and rural satellite locations to innovative outpatient environments.

Virtual Incision Corporation develops miniaturized robotic-assisted surgery (miniRAS) systems designed to democratize access to robotic-assisted surgery across healthcare facilities. The company's flagship product, the MIRA Surgical System, is the first FDA-cleared miniaturized robotic platform weighing approximately two pounds and deployable through a single abdominal incision. Unlike traditional mainframe robotic surgery systems, MIRA enables hospitals to perform robotic-assisted procedures in outpatient and ambulatory surgery centers, reducing capital barriers and expanding surgical capacity. The system is designed for general surgery abdominal procedures including colon resection and hysterectomy, with demonstrated remote surgical capabilities. Founded in 2006 by Dr. Dmitry Oleynikov and Dr. Shane Farritor, Virtual Incision holds over 200 patents and has raised more than $100 million in funding. The company's mission centers on making minimally invasive robotic surgery accessible to more patients, surgeons, and healthcare facilities by providing cost-effective alternatives to large-footprint robotic systems.

Noah Medical is a medical device company specializing in robotic-assisted bronchoscopy systems. The company manufactures the Galaxy System, an intelligent robotic platform designed for pulmonary diagnostics and interventional procedures in the airway. The Galaxy System integrates advanced imaging, precision targeting, and adaptive workflow capabilities to enable minimally invasive navigation and sampling of lung lesions. Key features include real-time lesion localization, integrated digital tomosynthesis and augmented fluoroscopy imaging, and tool-in-lesion (TiLT+) technology for enhanced diagnostic confidence and workflow efficiency. The system targets interventional pulmonologists, thoracic surgeons, and hospital-based endoscopy/interventional suites. Clinical evidence demonstrates 96.7% diagnostic yield in lesion localization (Match 2 Study, 31-patient multi-center cohort), 95% diagnostic accuracy (Cleveland Clinic prospective/retrospective evaluation, 100-patient cohort), and favorable cost-benefit metrics (1.1 OR ratio, 1.4 EndoSuite ratio in community hospital settings). The Galaxy System is intended for real-time imaging-guided bronchoscopic diagnosis and tissue sampling in patients with suspected lung malignancy or other pulmonary pathology. Noah Medical serves hospital systems and ambulatory surgical centers across the United States, supporting both diagnostic yield optimization and operational efficiency.

Home Orthopedics is a leading distributor of orthopedic implants and robotic orthopedic surgeon assistance systems in Puerto Rico. The company supplies a comprehensive portfolio of orthopedic implants covering knee, hip, shoulder, elbow, and trauma applications, alongside sports medicine and biologic solutions. Home Orthopedics also distributes advanced robotic-assisted surgical systems to enhance precision and outcomes in orthopedic procedures. The company serves hospitals, surgical centers, and orthopedic practices throughout Puerto Rico, providing both implant supply and cutting-edge surgical technology support.

Precera Medical is a contract development and manufacturing organization (CDMO) serving medical device original equipment manufacturers (OEMs). The company specializes in precision manufacturing and engineering solutions for complex medical devices, with particular focus on surgical robotics, minimally invasive surgical systems, endoscopy, spine, motion preservation, and neurostimulation applications. Precera delivers end-to-end capabilities spanning design and process development, rapid prototyping, automation-enabled manufacturing, precision machining (multi-axis and Swiss turning), electrochemical machining, implant and instrument forging, secondary processing, and final assembly. The company emphasizes seamless scaling from prototype to production without risky technology transfers, maintaining quality assurance and regulatory compliance throughout the manufacturing lifecycle. Precera positions itself as a true extension of customer engineering teams, offering robust quality systems, preventive maintenance, new product introduction (NPI) support, and risk management practices. The company serves top-tier MedTech OEMs and is oriented toward supporting advanced, precision-critical device development with validation embedded from inception. No specific FDA, ISO, or CE certifications are explicitly stated on the website, though the quality and compliance messaging suggests regulated manufacturing operations.

Corin Group is a global orthopaedic medical device company specializing in robotic-assisted joint replacement systems and clinically proven implants. The company's flagship product, ApolloKnee™, is a comprehensive surgical workflow combining pre-operative planning via the BalanceBot™ algorithm, intraoperative robotic guidance with the Apollo™ Robot (a compact cutting guide), and post-operative data collection and cloud integration for continuous learning. The ApolloKnee platform has achieved FDA 510(k) clearance (USA), EU MDR approval, and TGA registration (Australia). Corin serves orthopedic surgeons and healthcare facilities globally, offering knee and hip replacement technologies designed to optimize surgical planning, precision bone resection, dynamic balance assessment, and patient outcomes. The company operates manufacturing and distribution centers across multiple continents, with direct offices in the United States (Raynham, MA and Milpitas, CA), Europe, Australia, and Japan, supported by an international partner network. Corin emphasizes surgeon-centric design, including intuitive controls (gesture-based or tablet interface) and integration of pre-, intra-, and post-operative data to support personalized surgical planning and long-term patient tracking.

PROCEPT BioRobotics is a medical device company specializing in robotic-assisted, ultrasound-guided treatment for benign prostatic hyperplasia (BPH) and men's health conditions. The company manufactures Aquablation therapy systems, a waterjet-based robotic platform for prostate tissue resection that preserves continence and sexual function. The flagship product is the HYDROS Robotic System, described as a next-generation, AI-powered platform for Aquablation therapy. The system uses computer-assisted treatment planning to enable precision tissue resection while maximizing preservation of important anatomical structures across prostates of all shapes and sizes. Aquablation therapy has demonstrated clinical efficacy for safe, effective, and durable symptom relief in published urological literature. The company serves urology departments and specialized surgical centers in the United States, supporting surgeons in performing minimally invasive BPH treatment. Products are designed for hospital operating rooms and urology surgical suites.

Neocis develops and commercializes Yomi, a robotic system for dental implant surgery and alveoloplasty procedures. The platform comprises hardware (a robotic surgical arm with haptic guidance), planning software (YomiPlan), and intraoperative guidance capabilities that integrate with digital dental workflows. The original Yomi and the newer Yomi S model assist clinicians in achieving submillimeter accuracy during implant placement while eliminating the need for physical surgical guides. The company markets to general dentists, prosthodontists, and oral & maxillofacial surgeons seeking to expand implant case complexity and practice volume. Over 100,000 implants have been placed robotically with Yomi systems. Clinical evidence in peer-reviewed literature demonstrates superior accuracy and predictability compared to freehand surgery and static guide techniques. Neocis provides clinician training, technical support, and ongoing software enhancements. The platform operates as a unified hardware-software ecosystem designed for single-visit or streamlined multi-visit workflows. Target markets include private dental practices, oral surgery centers, and academic institutions in North America.

DOMA Surgical (operating under the SavingEyes brand) develops patient safety products for use in operating rooms, with particular emphasis on laparoscopic and robotic da Vinci procedures. The company specializes in evidence-based product development addressing surgeon and anesthesiology needs to eliminate patient complications and prevent intraoperative injuries. Product development is collaborative, involving patients, nurses, surgeons, anesthesiologists, regulatory organizations, and the FDA to ensure high-quality and affordable safety solutions. The company's philosophy emphasizes unique solutions to common and uncommon patient safety conditions in the OR, aligned with WHO and JCAHO published guidelines. All products are developed from evidence-based medicine and clinical studies.

MicroPort is a global medical technology company founded in 1998 in Shanghai, China, specializing in the development, manufacturing, and distribution of innovative medical devices across cardiovascular, orthopedic, and neurological therapeutic areas. The company has established a strong international presence with products available in over 90 countries and manufacturing facilities in China, the United States, France, and the United Kingdom. MicroPort's diverse portfolio includes coronary drug-eluting stents, implantable pacemakers (including MRI-compatible models), cardiac rhythm management solutions, reconstructive joint devices, and surgical robotics platforms. With over 4,500 employees and more than 3,000 issued patents, the company has achieved over 260 product approvals worldwide. MicroPort is committed to improving patient quality of life through advanced medical technology, with emphasis on clinical excellence, device miniaturization, and reliable supply chain management across hospital and interventional settings.

Nautilus Surgical is a distributor and solutions partner specializing in high-quality microsurgical equipment and operating room systems for hospitals and manufacturers. The company represents leading international medical device manufacturers including Carl Zeiss Meditec, UFSK-OSYS, Otopront, Mizuho, Steribite, Surgix, Cuda Surgical, Barrier Technologies, Kogent Surgical, Hubly Surgical, Neurovision Medical Products, MediCapture, and TTI Medical. Product portfolio encompasses advanced surgical microscopy systems (ZEISS KINEVO 900 S with digital visualization and cobotic assistance), surgical tables optimized for ophthalmology and neurosurgery, ENT examination chairs (Otopront Sit Max One, BASIC PLUS Flat Top), spinal and neurosurgical instruments, single-use surgical sets, cranial access kits, intraoperative neuromonitoring devices, surgical light sources, fiberoptic cables, radiation protection solutions, and medical-grade video recording and documentation systems. Nautilus Surgical also offers ZEISS Certified factory-reconditioned instruments. The company serves multiple surgical specialties including ophthalmology, neurosurgery, spine surgery, ENT, and microsurgery. Known for knowledgeable sales consultants and reliable technical support to support surgical workflows across hospital operating rooms and ambulatory surgical centers.

Varian Medical Systems, a Siemens Healthineers company, specializes in cancer care solutions across the entire patient journey, including radiation oncology, adaptive therapy, interventional oncology, and image-guided treatment systems. Primary product lines include TrueBeam and Edge external beam radiotherapy systems with integrated image-guided capabilities, Ethos Therapy (an AI-powered adaptive intelligence platform for personalized cancer delivery), Halcyon platform for streamlined radiotherapy, RapidArc dynamic treatment planning, HyperSight imaging solution for enhanced real-time visualization, and IntelliBlate microwave ablation for interventional oncology. The company develops treatment planning software, dose calculation engines, and connected workflows for cancer centers. Products are FDA 510(k) cleared and serve hospital radiation oncology departments, cancer centers, and specialty clinics. Varian provides training, webinars, clinical education, and ongoing customer support. The organization conducts research in radiotherapy innovation and maintains partnerships with clinical institutions globally.

LEM Surgical AG is a Switzerland-based medical robotics company headquartered in Bern, specializing in next-generation hard tissue robotic surgical systems. The company develops and manufactures the Dynamis Robotic Surgical System, a humanoid robotic platform designed to assist surgeons in orthopedic and hard tissue procedures. The Dynamis system received US FDA clearance (510(k) K243326) in April 2025, establishing regulatory approval for clinical use in the United States. LEM Surgical emphasizes surgical focus and advanced robotics capabilities, positioning their technology as a comprehensive solution for hard tissue surgical applications including orthopedic procedures. Manufacturing and development occurs at the company's state-of-the-art facilities in Bern, Switzerland. The company maintains a diverse, internationally composed team with deep expertise in robotics, automation, and surgical technology. LEM Surgical targets hospital operating rooms and surgical centers seeking robotic-assisted capabilities for orthopedic and hard tissue interventions.

Levita Magnetics International Corp. is a medical device company specializing in magnetic surgical technology for minimally invasive procedures. The company's flagship product, MARS™ (Magnetic Autonomously Retractable System), is a first-of-its-kind robotic surgical platform that leverages magnetic technology to enhance precision and accessibility in surgical care. MARS has received FDA clearance and represents a novel approach to minimally invasive surgery by harnessing magnetic and robotic mechanisms. The platform has been deployed in commercial surgical cases and recent applications include AI-guided autonomous surgical camera systems that enhance procedural precision and efficiency. Levita Magnetics markets its technology to hospitals and surgical centers seeking to expand minimally invasive surgical capabilities and improve patient outcomes through advanced magnetic surgery techniques. The company emphasizes patient accessibility and the reduction of surgical invasiveness as core mission drivers.

Asensus Surgical, Inc. is a medical device company specializing in robotic-assisted surgical systems and augmented intelligence solutions for the operating room. The company manufactures the Senhance® Surgical System, a robotic platform designed to provide surgeons with enhanced control, precision, and real-time decision support during minimally invasive procedures. The Senhance system features an innovative open ergonomic design that improves surgeon communication and physical comfort while maintaining intra-operative control. A cornerstone of Asensus's technology is the Intelligent Surgical Unit™ (ISU™), an intra-operative augmented intelligence system approved globally that delivers real-time surgical insights to enhance decision-making, reduce variability, and improve procedural outcomes. The ISU represents the company's Performance-Guided Surgery™ platform, which layers advanced robotics with reusable 3mm and 5mm articulating surgical instruments to extend safer, more predictable surgical care beyond traditional robotic-assisted surgery models. Asensus markets its systems to hospital operating rooms, surgical centers, and healthcare institutions globally, targeting surgeons seeking to perform safer, more accessible robotic-assisted procedures. The company has received multiple industry recognitions including Digital Health Awards and Surgical Robotics Industry Award nominations. While specific FDA 510(k) status and detailed regulatory certifications are not explicitly stated in available content, the site indicates the ISU is approved for use globally, suggesting appropriate regulatory clearances. The company is headquartered in Durham, North Carolina, and maintains an international team of physician partners and clinical collaborators.

Medical Microinstruments, Inc. (MMI) is the global leader in robotic microsurgery, designing and manufacturing the Symani® Surgical System—a breakthrough robotic platform uniquely engineered for microsurgery and supermicrosurgery. The system provides surgeons unmatched precision, consistency, and control for complex reconstructive and vascular procedures at the micro level. Core Product: The Symani Surgical System features the NanoWrist® instrument platform, which incorporates the world's smallest robotic wrist and replicates natural hand movements to enable precise intraoperative tasks including dissection, anastomosis, and supermicrosurgical repair. The company has introduced the world's first microsurgical suture designed specifically for robotic application. Clinical Applications: Symani supports multiple surgical specialties, including lymphatic reconstruction (lymphovenous anastomosis for lymphedema), autologous breast cancer reconstruction, head and neck cancer reconstruction, and trauma-related microvascular repair. Published clinical evidence demonstrates superior outcomes: 100% anastomosis patency on 2mm vessels versus 80% with manual techniques, 86% of lymphedema patients achieving limb-volume reduction, and >50% reduction in flap loss rates compared to manual microsurgery. Regulatory Status: The Symani Surgical System is FDA-authorized for use in the United States and CE-marked in Europe. The system is manufactured in Pisa, Italy. Company Position: MMI positions itself at the intersection of advanced robotics and digital innovation, targeting academic medical centers, specialty surgical centers, and plastic and reconstructive surgery programs performing complex microsurgery. The company provides surgeon training and certification, reimbursement support, and technical customer support.

Schivo is a vertically integrated contract manufacturer specializing in high-quality medical device components, sub-assemblies, and final assemblies for minimally invasive surgical systems, robotic-assisted surgical platforms, cardiovascular and neurovascular devices, and orthopedic implants. The company operates globally with best-practice manufacturing facilities and applies design-for-manufacturability principles to optimize cost, productivity, and time-to-market for OEM partners. Schivo's AFP division manufactures ultra-reliable fluid control components and sub-assemblies for laboratory chromatography instruments, genomic analysis systems, and clinical diagnostic platforms. The company provides full contract manufacturing services including new product introduction (NPI) with early-stage design-to-manufacturing integration, process qualification and validation using ISO-qualified methodologies, and comprehensive regulatory support for FDA submissions. All manufacturing processes are tracked and documented through the company's manufacturing management platform. Schivo is FDA-registered and complies with FDA quality system requirements and ISO standards. The company serves global medical device OEMs across surgical, diagnostic, and life science markets, offering value-added services that extend beyond component manufacturing to include design optimization, risk mitigation, and supply chain integration.

Evolve Manufacturing Technologies Inc. is a contract manufacturer of complex medical devices and life sciences instruments, operating a 75,000 sq ft facility in Fremont, California. The company specializes in end-to-end manufacturing services for original equipment manufacturers (OEMs) across multiple medical specialties including surgical robotics, capital medical devices, disposable surgical tools, and life sciences biotech applications. Their service portfolio encompasses design-to-manufacturing support, full production runs, repairs and spares management, and quality-assured supply chain solutions. Evolve holds ISO 13485:2016 and ISO 9001:2015 certifications, demonstrating compliance with medical device quality management standards. The facility includes ISO 14644-certified cleanrooms (ISO 7 and ISO 8 classifications), essential for sterile device and precision component manufacturing. The company serves Fortune 500 OEMs and established medtech innovators across surgical robotics, ultrasound imaging, spinal implants, and semiconductor robotics sectors. Evolve positions itself as a collaborative partner rather than transactional supplier, offering flexibility in production scaling, component sourcing, and logistics support. The company is woman-owned and has received industry recognition including the 2025 Global Technology Award for Best Woman-Owned Contract Manufacturer.

Brainlab is a Munich-headquartered medical technology company specializing in digital surgical ecosystems, robotic-assisted surgery, and intraoperative imaging platforms. The company designs integrated software and hardware solutions for neurosurgery, orthopedic spine surgery, radiosurgery, and craniomaxillofacial procedures. Core product lines include the Brainlab Robotic Suite (robotic-assisted surgical systems), Loop-X (mobile robotic intraoperative CBCT imaging), Spine Mixed Reality Navigation, spinal planning software, Elements (radiosurgery planning and automation), and Craniomaxillofacial Planning software. Brainlab also manufactures surgical navigation systems, mixed-reality visualization platforms, and ultrasound-based intraoperative guidance tools. The company markets solutions globally to hospitals and surgical centers, supporting minimally invasive and open procedures. Regulatory credentials include CE marking and FDA clearances; the site references 510(k) submissions and compliance with international standards. Brainlab operates worldwide with headquarters in Munich-Riem, Germany, and maintains regional presence across North America, Europe, and Asia-Pacific. The company emphasizes end-to-end surgical ecosystem integration, enabling preoperative planning through intraoperative execution and has partnerships with academic medical centers and large health systems.

Precision Optics Corp. is a vertically integrated optical imaging systems and components manufacturer specializing in micro-precision optics for minimally invasive medical procedures. The company designs, prototypes, and manufactures CMOS endoscopic cameras, micro-optics assemblies (including custom lenses and prisms), fiber bundle scopes, and rod lens systems for endoscopy, 3D visualization, and robotic surgery applications. Their products serve challenging anatomical environments requiring miniaturization down to 0.37 mm lenses and 0.10 mm prisms, addressing applications in gastroenterology, laparoscopy, arthroscopy, and other minimally invasive surgical specialties. Precision Optics offers the Unity™ Imaging Platform, a modular, proven system supporting development from prototyping through production. The company combines opto-mechanical design, optical assembly expertise, and interdisciplinary engineering capabilities to deliver customized solutions meeting specific clinical and manufacturing standards. Beyond medical devices, Precision Optics serves defense and aerospace sectors with micro-optical components. The firm is recognized as a domestic optics manufacturing partner with rapid response capabilities for complex imaging and illumination requirements in confined surgical spaces.

iotaMotion, Inc. is a medical technology company specializing in robotic-assisted surgical systems for cochlear implant procedures. Founded in 2015 by otolaryngologists from the University of Iowa Hospitals and Clinics, the company develops precision surgical platforms designed to enhance electrode array insertion during cochlear implant surgery. The flagship iotaSOFT® Insertion System is an open-platform robotic system that standardizes insertion speed and force control, reducing surgical variability while preserving residual hearing and minimizing intracochlear trauma. The system is designed for patients aged 4 years and older and is currently deployed across 25 surgical centers in the United States. iotaMotion addresses a significant clinical need—more than 430 million people worldwide experience disabling hearing loss—by improving surgical precision, reducing patient anxiety through standardized procedures, and enabling broader access to cochlear implantation. The company's technology supports surgeons through controlled, consistent insertion techniques while offering hospitals cost-effective implementation and patients improved standardized outcomes.

Meril Life Sciences is a global medical device manufacturer headquartered in Vapi, Gujarat, India, and founded in 2006. The company designs and manufactures innovative medical devices across multiple therapeutic specialties including cardiovascular interventions, orthopedic implants, minimally invasive endoscopic surgery tools, surgical robotics, and diagnostics. Meril operates as a multinational enterprise with 100% subsidiaries and regional headquarters spanning North America, Europe, Asia, Africa, and Australia. The company maintains a dedicated research and development function collaborating with surgeons and medical experts worldwide to address unmet clinical needs. Meril's product portfolio includes transcatheter heart valve systems (Myval THV and variants), orthopedic solutions through its Maxx Orthopedics division, endoscopic and minimally invasive surgical instruments, and robotic surgical platforms. The organization emphasizes clinical evidence generation and professional education through Meril Academy, a global platform offering fellowship programs and knowledge-sharing initiatives for healthcare professionals. Manufacturing and distribution capabilities span multiple continents, with established compliance and regulatory frameworks for markets including the United States, European Union, and Asia-Pacific regions. The company serves hospital systems, surgical centers, and healthcare institutions globally, with particular focus on advancing surgical interventions in cancer care and cardiovascular disease management.

Sharp Fluidics is a surgical technology company specializing in innovative robotic and laparoscopic closure solutions. The company manufactures the NeoClose® system, a robotic and laparoscopic closure platform designed to improve safety and efficiency in surgical workflows. The NeoClose system represents a non-closed-loop closure mechanism that reduces tension on the peritoneum, decreasing postoperative pain while offering speed, ease of use, and cost-effectiveness. The product is currently distributed exclusively through Medline, a major medical supply partner. The company focuses on minimally invasive surgical applications and has garnered clinical endorsement from practicing surgeons at leading medical institutions such as Cedars-Sinai Marina Del Rey Hospital. Sharp Fluidics targets operating room environments and surgical teams seeking to optimize closure techniques while maintaining clinical outcomes and reducing procedural complexity. The company emphasizes clinically-validated solutions that balance innovation with practical surgical workflow integration.

McGinley Orthopedic Innovations is a physician-led medical device company specializing in advanced surgical technologies for orthopedic procedures. The company's flagship product, IntelliSense HandHeld Robotics, is a robotic drill system deployed in operating rooms globally to enhance surgical precision and patient safety. The system integrates multi-sensor technology to optimize drilling accuracy, screw sizing, and screw placement while reducing complications. McGinley Orthopedics focuses on engineering solutions that increase technical confidence and efficiency in common orthopedic procedures, thereby improving patient outcomes and reducing overall medical costs. The company holds multiple U.S. patents with additional patents pending.

eCential Robotics is a surgical robotics company specializing in an open, unified platform integrating 2D/3D imaging, real-time navigation, and robotic systems for bone surgery. Founded in 2009 and headquartered in Grenoble, France, with US operations in Franklin, Tennessee, the company serves orthopedic and neurosurgery markets with over 3,500 completed procedures. The platform is implant-agnostic, supporting third-party surgical app development and compatible with implants from multiple manufacturers, allowing surgeons to select the optimal technique and device for each patient. Key features include integrated imaging and navigation within a single interface, support for minimally invasive approaches, and multi-specialty surgical applications. With over 100 patents and approximately 105 employees, eCential Robotics focuses on digitalizing traditional surgical techniques to enhance patient safety, surgeon precision, and operational efficiency in the OR.

Imperative Care is a medical technology company specializing in innovative solutions for stroke and vascular disease interventions. Founded in 2016, the company operates four business units addressing the complete patient journey from acute intervention to post-acute recovery. The Imperative Care Stroke unit develops interventional devices including the Zoom Stroke System for rapid mechanical clot removal across a wide range of vessels in ischemic stroke patients. The Vascular unit offers the Symphony® Thrombectomy System for venous thromboembolism treatment and the Prodigy® Thrombectomy System for acute limb ischemia management. Telos Health is developing a robotic platform to enhance precision, standardization, and accessibility of vascular procedures. Kandu Health provides digital health support for stroke survivors. The company emphasizes rapid clinical innovation and partnerships with healthcare providers to improve patient outcomes across the stroke and vascular disease spectrum.

Activ Surgical is a Boston-based digital surgery company specializing in hardware-agnostic surgical software and intraoperative imaging technologies designed to enhance visualization and reduce surgical errors. The company's flagship product, ActivSight™ Intelligent Light, is FDA-cleared and integrates with existing laparoscopic and robotic surgical systems to provide real-time visualization of blood flow and tissue perfusion. ActivSight offers surgeons critical physiological insights invisible to the naked eye through dye-free ActivPerfusion™ and ActivICG™ imaging modes. The patent-protected ActiveEdge™ platform leverages augmented reality, artificial intelligence, and machine learning to improve intraoperative decision-making and address preventable surgical complications. Activ Surgical has achieved significant milestones including the world's first autonomous robotic surgery of soft tissue and CE Mark approval. With $87.5 million in funding, the company operates pilot sites in major U.S. hospital networks, addressing the critical clinical need that preventable surgical errors contribute to over 400,000 deaths annually in the U.S.

CMR Surgical Ltd develops and manufactures the Versius Plus robotic-assisted surgical system, a compact, modular platform designed for minimally invasive surgery. The Versius Plus is FDA 510(k) cleared for cholecystectomy and represents the second most utilized robotic surgical platform globally, with over 45,000 cases performed worldwide. The system features a modular design requiring no dedicated operating room, enabling flexible port placement and seamless switching between robotic and non-robotic procedures. Key technological components include vLimeLite, an integrated fluorescence visualization system with indocyanine green (ICG) imaging capability, multiple visualization modes, and a 26-inch 3DHD display. The platform integrates a full suite of fully articulated surgical instruments with both electrosurgical and non-electrosurgical capabilities. CMR Surgical's ecosystem includes software-driven features such as Versius Connect (surgeon procedural logbook) and Versius Team (hospital dashboard for usage tracking, case volume, and system efficiency monitoring). The company operates globally with headquarters in Cambridge, UK, and regional offices across India, Italy, Brazil, Germany, Poland, France, and Spain. Manufacturing and R&D operations are based in the UK with additional technology and operations facilities in Ely. The company has secured significant funding exceeding $200 million to accelerate US market expansion and product development.

Distalmotion SA is a Switzerland-headquartered medical device company founded in 2012, specializing in robotic-assisted surgical systems designed to expand access to minimally invasive surgery. The company develops and markets the DEXTER® Robotic Surgery System, a compact, integrated platform engineered to simplify robotic surgical workflows and enable deployment across diverse operating room environments, including outpatient facilities. DEXTER is designed for compatibility with existing hospital infrastructure and surgeon preferences, reducing barriers to robotics adoption compared to larger, more complex systems. The system targets general surgeons, surgical specialists, and hospital systems seeking to establish or expand robotic surgery capabilities without substantial operational disruption. The company operates globally with a multinational team based in Lausanne, Switzerland. While specific regulatory certifications (FDA clearance status, 510(k), CE marking) are not explicitly detailed in the fetched content, the company's positioning as a commercial medical device provider suggests appropriate regulatory compliance. DEXTER is positioned as a user-centric alternative to incumbent robotic platforms, emphasizing surgeon ergonomics, workflow integration, and institutional scalability. The company serves hospitals, healthcare providers, and surgeons across multiple care settings. Manufacturing and regulatory credentials require verification via additional sources.

Freehold Surgical manufactures fully adjustable, hands-free intracorporeal organ retractors for minimally invasive surgical procedures. The company's core product portfolio includes the FreeHold Duo and FreeHold Trio retractors, which are proprietary mechanical devices designed for robotic and laparoscopic surgery. These retractors enable surgeon autonomy while optimizing visualization and minimizing incisions across a broad range of surgical applications, including cholecystectomy, hepatic procedures, and general tissue manipulation. The devices are completely intracorporeal, meaning they work entirely within the body cavity without requiring external engagement. FreeHold Surgical's retractors are fully and continuously adjustable, designed for ease of learning and teaching in the OR. The company serves surgical teams in hospital and ambulatory settings, targeting general surgery, hepatobiliary, and laparoscopic specialties. Manufacturing and regulatory details are not explicitly disclosed on the site, though the product branding and clinical positioning suggest medical device manufacturing and distribution operations. The company is based in New Hope, Pennsylvania.

US Medical Innovations, LLC (USMI), headquartered in Takoma Park, Maryland, develops advanced surgical and oncological technologies focused on cold plasma ablation and robotic surgical systems. The company manufactures the Canady Helios™ Cold Plasma Ablation System, an FDA 510(k)-cleared device (K240297) designed for soft tissue ablation during surgical procedures, particularly for treating positive microscopic margins in solid tumor resection without damaging adjacent normal tissue. USMI also produces the Canady Flex RoboWrist™, an FDA-approved robotic surgical device for use in open and laparoscopic procedures. The company has completed Phase I IDE clinical trials demonstrating statistically significant efficacy in treating advanced and recurrent solid tumors (Stage 4), with peer-reviewed results published in MDPI's Cancers journal. USMI is affiliated with the Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS) and operates as a biomedical and life sciences subsidiary of US Patent Innovations, LLC. The company serves surgical oncologists, orthopedic surgeons, and general surgeons at major medical institutions including Rush University and international centers such as Sheeba Medical Center in Israel. Products employ cold atmospheric plasma physics technology for intraoperative tissue ablation and are positioned for oncologic, orthopedic, and general surgical applications.

Accuray Incorporated is a global leader in radiation oncology and radiosurgery systems. The company manufactures advanced treatment platforms designed to deliver precise radiation therapy across a full spectrum of patient needs, with 479+ systems installed in 33+ countries. Accuray's primary product lines include the CyberKnife® S7™, a robotic stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) system featuring AI-driven real-time motion synchronization for tumor treatment anywhere in the body, and the Radixact® system, which combines integrated 3D kVCT and megavoltage CT (MVCT) imaging for image-guided intensity-modulated radiation therapy (IG-IMRT) and 3D conformal radiation therapy (3DCRT). Both systems are designed to improve treatment precision, reduce workflow complexity, and enhance patient outcomes. Accuray serves oncology centers, hospitals, and specialized radiotherapy facilities globally. The company emphasizes quality of care, efficiency of workflow, and clinician confidence through continuous innovation. Over 31% of system components are sourced from U.S. suppliers. Accuray supports its installed base through comprehensive training programs, the AEx® peer community platform for user education and experience-sharing, and dedicated service and reimbursement support. The company operates in the high-stakes cancer treatment market, addressing complex cases including prostate, lung, brain, and other tumor types.

MicroPort Orthopedics Inc. is an orthopedic medical device manufacturer specializing in joint reconstruction implants and robotic-assisted surgical systems. The company has 50 years of orthopedic implant manufacturing experience and markets products across 70 countries worldwide. Primary product lines include total knee replacement systems, total hip replacement systems, and the SkyWalker® robotic-assisted surgical platform. The Evolution® Medial-Pivot Knee is a flagship product offering validated long-term clinical outcomes (25-year track record) and features proprietary kinematic design. The Evolution® NitrX™ Knee incorporates a titanium niobium nitride (TiNbN) coating designed to reduce metallic ion release common in standard CoCr implants. Hip offerings emphasize tissue-sparing surgical approaches such as SuperPath®, designed to reduce hospital length of stay and improve patient recovery. The SkyWalker® Surgical Robot is FDA-cleared in the U.S. and CE-marked internationally; distributed by MicroPort through partnership with MicroPort NaviBot International LLC. The company reports continuous innovation with 10 new products launched in the last 3 years. Manufacturing and distribution infrastructure supports hospital and surgical center customers globally.

Monogram Technologies (now part of Zimmer Biomet as of 2025) develops precision robotic surgical systems and personalized orthopedic implant solutions for joint reconstruction. The company's core platform combines navigated surgical robotics with custom 3D-printed implant technology to enable highly personalized joint replacement procedures. The mBôs robotic system delivers precision bone cuts calibrated to individual patient anatomy, while the mVision registration and tracking technology integrates image-guided surgical navigation. Monogram's proprietary software automates clinical workflows, processes patient imaging data using machine learning algorithms, and optimizes implant positioning and alignment. The company targets the $20 billion orthopedic surgery market, specifically addressing limitations in knee and hip replacement procedures. Published research indicates Monogram's technique achieves approximately seven times greater stability compared to conventional hip replacement methods. The company has conducted clinical validation studies with UCLA and maintains an active SEC-registered securities offering. As a Zimmer Biomet subsidiary, Monogram leverages the parent company's regulatory infrastructure and distribution network. Products remain in development and early clinical validation stages.

ARCH Medical Solutions is a contract manufacturer of precision-machined medical devices, surgical instruments, implants, and robotic components for medical OEMs. Operating FDA-registered and ISO 13485-certified facilities nationwide, the company specializes in orthopedic implants, spine devices, dental instruments, and surgical robotics manufacturing. Core manufacturing capabilities include precision CNC machining, additive manufacturing (powder-bed fusion), medical grinding (flute, drill-point, thread grinding), and mechanical assembly. The company serves orthopedics, surgical robotics, dental, and life sciences markets, offering design-for-manufacturability expertise, prototype-to-production workflows, and supply chain integration. ARCH manufactures high-tolerance gears, subassemblies, end effectors, and finished surgical instruments in medical-grade stainless steel and various alloys. The company emphasizes rapid turnaround on specialty and make-to-order instruments with lead times measured in days, supported by technical engineering staff and validated manufacturing processes. All products meet stringent medical industry tolerances and quality standards.

Zimmer Biomet is a leading global medical technology company specializing in orthopedic implants, surgical robotics, and digital health solutions. The company manufactures and distributes a comprehensive portfolio of joint replacement systems, trauma devices, spine products, and minimally invasive surgical instruments. Core product lines include the Persona knee system, Z1 hip system, ROSA robotic surgery platform, and specialized solutions for foot & ankle, shoulder, elbow, and sports medicine applications. The company also offers digital care management platforms (mymobility) and AI-enabled surgical navigation systems. Zimmer Biomet serves orthopedic surgeons, hospitals, and surgical centers globally with FDA-cleared and CE-marked devices. Manufacturing capabilities span multiple facilities in North America and internationally, with regulatory compliance including FDA 510(k) clearances and ISO certifications. The company provides comprehensive support including surgical education, training, reimbursement assistance, and equipment servicing. Additionally, Zimmer Biomet distributes specialty products in CMF (craniomaxillofacial), thoracic, trauma, and other surgical specialties through strategic business units.